Longitudinal Assessment of Neuroradiologic Features in Wolfram Syndrome

References

1. 1.↵
   1. Amr S,
   2. Heisey C,
   3. Zhang M, et al

   . A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2. Am J Hum Genet 2007;81:673–83 doi:10.1086/520961 pmid:17846994

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Inoue H,
   2. Tanizawa Y,
   3. Wasson J, et al

   . A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 1998;20:143–48 doi:10.1038/2441 pmid:9771706

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Cagalinec M,
   2. Liiv M,
   3. Hodurova Z, et al

   . Role of mitochondrial dynamics in neuronal development: mechanism for Wolfram syndrome. PLoS Biol 2016;14:e1002511 doi:10.1371/journal.pbio.1002511 pmid:27434582

   CrossRefPubMed
4. 4.↵
   1. Takei D,
   2. Ishihara H,
   3. Yamaguchi S, et al

   . WFS1 protein modulates the free Ca(2+) concentration in the endoplasmic reticulum. FEBS Lett 2006;580:5635–40 doi:10.1016/j.febslet.2006.09.007 pmid:16989814

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Delprat B,
   2. Maurice T,
   3. Delettre C

   . Wolfram syndrome: MAMs’ connection? Cell Death Dis 2018;9:364 doi:10.1038/s41419-018-0406-3 pmid:29511163

   CrossRefPubMed
6. 6.↵
   1. Alfaro R,
   2. Doty T,
   3. Narayanan A, et al

   . Taste and smell function in Wolfram syndrome. Orphanet J Rare Dis 2020;15:57 doi:10.1186/s13023-020-1335-7 pmid:32087739

   CrossRefPubMed
7. 7.↵
   1. Rove KO,
   2. Vricella GJ,
   3. Hershey T, et al

   . Lower urinary tract dysfunction and associated pons volume in patients with Wolfram syndrome. J Urol 2018;200:1107–13 doi:10.1016/j.juro.2018.06.002 pmid:29883657

   CrossRefPubMed
8. 8.↵
   1. Pickett KA,
   2. Duncan RP,
   3. Paciorkowski AR, et al

   ; Washington University Wolfram Study Group. Balance impairment in individuals with Wolfram syndrome. Gait Posture 2012;36:619–24 doi:10.1016/j.gaitpost.2012.06.008 pmid:22771154

   CrossRefPubMed
9. 9.↵
   1. Pickett KA,
   2. Duncan RP,
   3. Hoekel J, et al

   ; Washington University Wolfram Study Group. Early presentation of gait impairment in Wolfram syndrome. Orphanet J Rare Dis 2012;7:92 doi:10.1186/1750-1172-7-92 pmid:23217193

   CrossRefPubMed
10. 10.↵
    1. Lugar HM,
    2. Koller JM,
    3. Rutlin J, et al

    . Evidence for altered neurodevelopment and neurodegeneration in Wolfram syndrome using longitudinal morphometry. Sci Rep 2019;9:6010 doi:10.1038/s41598-019-42447-9 pmid:30979932

    CrossRefPubMed
11. 11.↵
    1. Lugar HM,
    2. Koller JM,
    3. Rutlin J, et al

    ; Washington University Wolfram Syndrome Research Study Group. Neuroimaging evidence of deficient axon myelination in Wolfram syndrome. Sci Rep 2016;6:21167 doi:10.1038/srep21167 pmid:26888576

    CrossRefPubMed
12. 12.↵
    1. Samara A,
    2. Rahn R,
    3. Neyman O, et al

    . Developmental hypomyelination in Wolfram syndrome: new insights from neuroimaging and gene expression analyses. Orphanet J Rare Dis 2019;14:279 doi:10.1186/s13023-019-1260-9 pmid:31796109

    CrossRefPubMed
13. 13.↵
    1. Gocmen R,
    2. Guler E

    . Teaching NeuroImages: MRI of brain findings of Wolfram (DIDMOAD) syndrome. Neurology 2014;83:e213–14 doi:10.1212/WNL.0000000000001082 pmid:25488999

    Abstract/FREE Full Text
14. 14.↵
    1. Ito S,
    2. Sakakibara R,
    3. Hattori T

    . Wolfram syndrome presenting marked brain MR imaging abnormalities with few neurologic abnormalities. AJNR Am J Neuroradiol 2007;28:305–06 pmid:17297000

    Abstract/FREE Full Text
15. 15.↵
    1. Scolding NJ,
    2. Kellar-Wood HF,
    3. Shaw C, et al

    . Wolfram syndrome: hereditary diabetes mellitus with brainstem and optic atrophy. Ann Neurol 1996;39:352–60 doi:10.1002/ana.410390312 pmid:8602754

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Bischoff AN,
    2. Reiersen AM,
    3. Buttlaire A, et al

    ; Washington University Wolfram Syndrome Research Group. Selective cognitive and psychiatric manifestations in Wolfram syndrome. Orphanet J Rare Dis 2015;10:66 doi:10.1186/s13023-015-0282-1 pmid:26025012

    CrossRefPubMed
17. 17.↵
    1. Marshall BA,
    2. Permutt MA,
    3. Paciorkowski AR, et al

    ; Washington University Wolfram Study Group. Phenotypic characteristics of early Wolfram syndrome. Orphanet J Rare Dis 2013;8:64 doi:10.1186/1750-1172-8-64 pmid:23981289

    CrossRefPubMed
18. 18.↵
    1. Hershey T,
    2. Lugar HM,
    3. Shimony JS, et al

    ; Washington University Wolfram Study Group. Early brain vulnerability in Wolfram syndrome. PLoS One 2012;7:e40604 doi:10.1371/journal.pone.0040604 pmid:22792385

    CrossRefPubMed
19. 19.↵
    1. Harsha KJ,
    2. Parameswaran K

    . Wolfram (DIDMOAD) syndrome with ventral central pontine hyperintensity without brainstem atrophy. Neurol India 2016;64:1310–12 doi:10.4103/0028-3886.193793 pmid:27841206

    CrossRefPubMed
20. 20.↵
    1. Cohen J

    . A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37–46 doi:10.1177/001316446002000104

    CrossRefWeb of Science
21. 21.↵
    1. Landis JR,
    2. Koch GG

    . The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74 pmid:843571

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Bonneville F,
    2. Cattin F,
    3. Marsot-Dupuch K, et al

    . T1 signal hyperintensity in the sellar region: spectrum of findings. Radiographics 2006;26:93–113 doi:10.1148/rg.261055045 pmid:16418246

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Fujisawa I,
    2. Asato R,
    3. Kawata M, et al

    . Hyperintense signal of the posterior pituitary on T1-weighted MR images: an experimental study. J Comput Assist Tomogr 1989;13:371–77 doi:10.1097/00004728-198905000-00001 pmid:2723165

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Kucharczyk W,
    2. Lenkinski RE,
    3. Kucharczyk J, et al

    . The effect of phospholipid vesicles on the NMR relaxation of water: an explanation for the MR appearance of the neurohypophysis? AJNR Am J Neuroradiol 1990;11:693–700 pmid:2114751

    Abstract/FREE Full Text
25. 25.↵
    1. Klyn V,
    2. Dekeyzer S,
    3. Van Eetvelde R, et al

    . Presence of the posterior pituitary bright spot sign on MRI in the general population: a comparison between 1.5 and 3T MRI and between 2D-T1 spin-echo- and 3D-T1 gradient-echo sequences. Pituitary 2018;21:379–83 doi:10.1007/s11102-018-0885-3 pmid:29594809

    CrossRefPubMed
26. 26.↵
    1. Fujisawa I,
    2. Nishimura K,
    3. Asato R, et al

    . Posterior lobe of the pituitary in diabetes insipidus: MR findings. J Comput Assist Tomogr 1987;11:221–25 doi:10.1097/00004728-198703000-00004 pmid:3819118

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Wang S,
    2. Lin K,
    3. Xiao D, et al

    . The relationship between posterior pituitary bright spot on magnetic resonance imaging (MRI) and postoperative diabetes insipidus for pituitary adenoma patients. Med Sci Monit 2018;24:6579–86 doi:10.12659/MSM.908349 pmid:30228254

    CrossRefPubMed
28. 28.↵
    1. Elli FM,
    2. Ghirardello S,
    3. Giavoli C, et al

    . A new structural rearrangement associated to Wolfram syndrome in a child with a partial phenotype. Gene 2012;509:168–72 doi:10.1016/j.gene.2012.06.077 pmid:22771918

    CrossRefPubMed
29. 29.↵
    1. Shepherd TM,
    2. Ades-Aron B,
    3. Bruno M, et al

    . Direct in vivo MRI discrimination of brain stem nuclei and pathways. AJNR Am J Neuroradiol 2020;41:777–84 doi:10.3174/ajnr.A6542 pmid:32354712

    Abstract/FREE Full Text
30. 30.↵
    1. Doherty D,
    2. Millen KJ,
    3. Barkovich AJ

    . Midbrain and hindbrain malformations: advances in clinical diagnosis, imaging, and genetics. Lancet Neurol 2013;12:381–93 doi:10.1016/S1474-4422(13)70024-3 pmid:23518331

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Genis D,
    2. Davalos A,
    3. Molins A, et al

    . Wolfram syndrome: a neuropathological study. Acta Neuropathol 1997;93:426–29 doi:10.1007/s004010050635 pmid:9113209

    CrossRefPubMed
32. 32.↵
    1. Shannon P,
    2. Becker L,
    3. Deck J

    . Evidence of widespread axonal pathology in Wolfram syndrome. Acta Neuropathol 1999;98:304–08 doi:10.1007/s004010051084 pmid:10483789

    CrossRefPubMed
33. 33.↵
    1. Hilson JB,
    2. Merchant SN,
    3. Adams JC, et al

    . Wolfram syndrome: a clinicopathologic correlation. Acta Neuropathol 2009;118:415–28 doi:10.1007/s00401-009-0546-8 pmid:19449020

    CrossRefPubMed
34. 34.↵
    1. Scaramuzzi M,
    2. Kumar P,
    3. Peachey N, et al

    . Evidence of retinal degeneration in Wolfram syndrome. Ophthalmic Genet 2019;40:34–38 doi:10.1080/13816810.2018.1551494 pmid:30507261

    CrossRefPubMed
35. 35.↵
    1. Hoekel J,
    2. Narayanan A,
    3. Rutlin J, et al

    . Visual pathway function and structure in Wolfram syndrome: patient age, variation and progression. BMJ Open Ophth 2018;3:e000081 doi:10.1136/bmjophth-2017-000081 pmid:29657975

    Abstract/FREE Full Text
36. 36.↵
    1. Pakdemirli E,
    2. Karabulut N,
    3. Bir LS, et al

    . Cranial magnetic resonance imaging of Wolfram (DIDMOAD) syndrome. Australas Radiol 2005;49:189–91 doi:10.1111/j.1440-1673.2005.01420.x pmid:15845065

    CrossRefPubMed
37. 37.↵
    1. Zhuang FJ,
    2. Chen Y,
    3. He WB, et al

    . Prevalence of white matter hyperintensities increases with age. Neural Regen Res 2018;13:2141–46 doi:10.4103/1673-5374.241465 pmid:30323144

    CrossRefPubMed
38. 38.↵
    1. Chaussenot A,
    2. Bannwarth S,
    3. Rouzier C, et al

    . Neurologic features and genotype-phenotype correlation in Wolfram syndrome. Ann Neurol 2011;69:501–08 doi:10.1002/ana.22160 pmid:21446023

    CrossRefPubMed
39. 39.↵
    1. Galluzzi P,
    2. Filosomi G,
    3. Vallone IM, et al

    . MRI of Wolfram syndrome (DIDMOAD). Neuroradiology 1999;41:729–31 doi:10.1007/s002340050832 pmid:10552021

    CrossRefPubMedWeb of Science